• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺钼靶检测到的导管原位癌的细胞形态学和结构异质性比较。

Comparison of cytomorphological and architectural heterogeneity in mammographically-detected ductal carcinoma in situ.

作者信息

Harrison M, Coyne J D, Gorey T, Dervan P A

机构信息

Department of Pathology, Mater Misericordiae Hospital, University College Dublin, Ireland.

出版信息

Histopathology. 1996 May;28(5):445-50. doi: 10.1046/j.1365-2559.1996.322365.x.

DOI:10.1046/j.1365-2559.1996.322365.x
PMID:8735720
Abstract

Many classification schemes have been proposed for ductal carcinoma in situ. Architectural heterogeneity is widely recognized. Cytonuclear grade appears to have greater prognostic significance than architectural pattern. This study assesses heterogeneity using a classification based on cytological grade and compares this to architectural heterogeneity in mammographically detected ductal carcinoma in situ. One hundred and twelve cases were classified according to architectural subtypes and the carcinoma nuclei were graded. Necrosis and microcalcification were assessed. Eighty-four percent of ductal carcinomas in situ had a single nuclear grade, whereas only 39% showed a single architectural pattern. High grade nuclei were present in 87% of cases. Necrosis was associated with high nuclear grade. In contrast to architectural heterogeneity, this study shows little ductal carcinoma in situ heterogeneity when classification is based on nuclear grade. Thus, a cytomorphological classification should have the advantage of consistency and reproducibility in comparison to architecture-based classification systems.

摘要

针对导管原位癌,已经提出了许多分类方案。结构异质性已得到广泛认可。细胞核分级似乎比结构模式具有更大的预后意义。本研究使用基于细胞学分级的分类方法评估异质性,并将其与乳腺钼靶检测到的导管原位癌的结构异质性进行比较。112例病例根据结构亚型进行分类,并对癌细胞核进行分级。评估坏死和微钙化情况。84%的导管原位癌具有单一的细胞核分级,而只有39%表现出单一的结构模式。87%的病例存在高级别细胞核。坏死与高细胞核分级相关。与结构异质性相反,本研究表明,当基于细胞核分级进行分类时,导管原位癌的异质性较小。因此,与基于结构的分类系统相比,细胞形态学分类应具有一致性和可重复性的优势。

相似文献

1
Comparison of cytomorphological and architectural heterogeneity in mammographically-detected ductal carcinoma in situ.乳腺钼靶检测到的导管原位癌的细胞形态学和结构异质性比较。
Histopathology. 1996 May;28(5):445-50. doi: 10.1046/j.1365-2559.1996.322365.x.
2
Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast.乳腺导管原位癌的细胞学和结构异质性。
J Clin Pathol. 1997 Jul;50(7):596-9. doi: 10.1136/jcp.50.7.596.
3
Ductal carcinoma in situ: a proposal for a new classification.导管原位癌:一种新分类的提议。
Semin Diagn Pathol. 1994 Aug;11(3):167-80.
4
Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast.乳腺导管原位癌病理学新分类方案的可重复性
J Clin Pathol. 1998 Jun;51(6):450-4. doi: 10.1136/jcp.51.6.450.
5
Breast pathology: rationale for adopting the ductal intraepithelial neoplasia (DIN) classification.乳腺病理学:采用导管原位上皮内瘤变(DIN)分类的基本原理。
Nat Clin Pract Oncol. 2005 Mar;2(3):116-7. doi: 10.1038/ncponc0109.
6
Intraductal carcinoma associated with invasive carcinoma of the breast. A comparison of the two lesions with implications for intraductal carcinoma classification systems.与乳腺浸润性癌相关的导管内癌。两种病变的比较及其对导管内癌分类系统的意义。
Am J Clin Pathol. 1996 Sep;106(3):312-8. doi: 10.1093/ajcp/106.3.312.
7
A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma.对六种现代乳腺导管原位癌(DCIS)分类的批判性评价:与相关浸润性癌分级的相关性
Histopathology. 1996 Nov;29(5):397-409. doi: 10.1046/j.1365-2559.1996.d01-513.x.
8
Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype.乳腺导管原位癌:乳腺钼靶钙化与肿瘤亚型之间的相关性
AJR Am J Roentgenol. 1992 Sep;159(3):483-5. doi: 10.2214/ajr.159.3.1323923.
9
Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ.伴有或不伴有非典型性的导管增生及导管原位癌的细针穿刺细胞学检查
Hum Pathol. 1994 May;25(5):485-92. doi: 10.1016/0046-8177(94)90120-1.
10
Nuclear chromatin characteristics of breast solid pattern ductal carcinoma in situ.乳腺实性原位导管癌的核染色质特征
Anal Quant Cytol Histol. 2001 Dec;23(6):418-26.

引用本文的文献

1
Morphological intratumor heterogeneity in ductal carcinoma in situ of the breast.乳腺导管原位癌的形态学肿瘤内异质性。
Virchows Arch. 2021 Jul;479(1):33-43. doi: 10.1007/s00428-021-03040-6. Epub 2021 Jan 27.
2
Molecular grading of ductal carcinoma in situ of the breast.乳腺导管原位癌的分子分级
Clin Cancer Res. 2008 Dec 15;14(24):8244-52. doi: 10.1158/1078-0432.CCR-08-0939.
3
Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast.用于乳腺导管原位癌(DCIS)分类的特征观察的一致性。
J Clin Pathol. 2000 Aug;53(8):596-602. doi: 10.1136/jcp.53.8.596.
4
Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast.乳腺导管原位癌的细胞学和结构异质性。
J Clin Pathol. 1997 Jul;50(7):596-9. doi: 10.1136/jcp.50.7.596.
5
Advances in breast cancer: clinical and biological lessons from screening.乳腺癌的进展:筛查中的临床与生物学经验教训
Ir J Med Sci. 1996 Jul-Sep;165(3):143-50. doi: 10.1007/BF02940236.